The Study of Pain Management Index (PMI) in Head and Neck Cancer Patients
Keywords:
pain management index, pain, head and neck cancerAbstract
Pain is one of the major problems for patients with head and neck cancer. An adequate level of pain management might increase patients’ quality of life. The Pain Management Index (PMI) is an indicator of adequate pain management. Studies on pain management indices in head and neck cancer, however, are lacking. The aim of this study was to assess the prevalence of inadequate pain management in head and neck cancer patients using the PMI. We used a cross-sectional descriptive study. The cancer hospital registered 150 patients with head and neck cancer as part of the sample. We purposefully selected the sample based on the characteristics of the inclusion criteria. Data were collected between March 20, 2024 and August 15, 2024. The research instruments consisted of a Thai version of the Brief Pain Inventory (BPI) pain questionnaire. The research instrument had a content validity index of 0.91 and a reliability (Cronbach’s alpha coefficient) for this sample group of 0.85. Data were analyzed using descriptive statistics.
The results showed that 65.33% of head and neck cancer patients were male, the average age of the sample was 59.31 years (S.D.=11.22). Most head and neck cancers were nasopharyngeal (52.00%). Most participants (58.00%) reported moderate pain. Paracetamol was the most used pain medication (36.00%), followed by tramadol (31.33%). The analysis of the PMI scores revealed that a significant proportion of participants (64.00%) received inadequate pain medication, as indicated by scores of -1 (50.00%), -2 (12.00%), and -3 (2.00%). Pain had the biggest impact on daily happiness and follow by sleep.
Downloads
References
Anekar, A. A., Hendrix, J. M., & Cascella, M. (2023). WHO analgesic ladder. In StatPearls [Internet]: StatPearls Publishing.
Bramati, P., & Bruera, E. (2022). The end of the second step of the World Health Organization analgesic ladder? Annals of Oncology, 33(12), 1212-1213.
Chaudakshetrin, P. (2009). Validation of the Thai Version of Brief Pain Inventory (BPI-T) in cancer patients.
Cleeland, C. S., Gonin, R., Hatfield, A. K., Edmonson, J. H., Blum, R. H., Stewart, J. A., & Pandya, K. J. (1994). Pain and its treatment in outpatients with metastatic cancer. New England Journal of Medicine, 330(9), 592-596.
Cramer, J. D., Johnson, J. T., & Nilsen, M. L. (2018). Pain in head and neck cancer survivors: prevalence, predictors, and quality-of-life impact. Otolaryngology–Head and Neck Surgery, 159(5), 853-858.
Gotur, A. J., & Chatterjee, A. (2023). Pain Severity and Quality of Life Following Major Mandibular Reconstructive Surgery in Head Neck Cancer. Indian Journal of Pain, 37(1), 20-26.
Hinther, A., Nakoneshny, S.C., Chandarana, S.P., Wayne Matthews, T., & Dort, J.C. (2018). Efficacy of postoperative pain management in head and neck cancer patients. Journal of Otolaryngology-Head & Neck Surgery, 47(1), 29.
Howren, M.B., Seaman, A., Super, G.L., Christensen, A.J., & Pagedar, N. A. (2023). Examination of predictors of pain at 12 months Postdiagnosis in head and neck cancer survivors. Otolaryngology–Head and Neck Surgery, 169(6), 1506-1512.
Khawaja, S.N., & Scrivani, S.J. (2022). Head and Neck Cancer-Related Pain. Dental Clinics of North America, 67(1), 129-140.
Kouri, M., Rekatsina, M., Vadalouca, A., Siafaka, I., Vardas, E., Papadopoulou, et al. (2022). Pharmacological management of neuropathic pain after radiotherapy in head and neck cancer patients: a systematic review. Journal of Clinical Medicine, 11(16), 4877.
Magaña, L.C., Murati, S., Riffitts, M., Harrison, C., Harris, A., Sowa, G., et al. (2021). Subjective and objective measures in assessing neck disability and pain in head and neck cancer. The Laryngoscope, 131(9), 2015-2022.
Mody, M.D., Rocco, J.W., Yom, S.S., Haddad, R.I., & Saba, N.F. (2021). Head and neck cancer. The Lancet, 398(10318), 2289-2299.
National Cancer Institute. (2024). Hospital-based cancer registry 2022. National Cancer Institute
Prasertsri, N., Phogsiri, P., Wamalun, C., Taptimhin, S., Teeyapan, W., & Charoennukul, A. (2023). Health Literacy, Symptoms and Self-Symptom Management of Head and Neck Cancer Patients’ ongoing Radiation Treatment. Nursing Journal of The Ministry of Public Health, 33(1), 161-174.
Schaller, A.K.S., Peterson, A., & Bäckryd, E. (2021). Pain management in patients undergoing radiation therapy for head and neck cancer–a descriptive study. Scandinavian Journal of Pain, 21(2), 256-265.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global cancer statistics 2020: Globocaan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249.
Zebralla, V., Wichmann, G., Pirlich, M., Hammermüller, C., Berger, T., Zimmermann, K., et al. (2021). Dysphagia, voice problems, and pain in head and neck cancer patients. European Archives of Oto-Rhino-Laryngology, 1-10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sirindhorn College of Public Health Ubon Ratchathani Province
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์ในวารสาร วารสารสาธารณสุขและสุขภาพศึกษา (Thai Journal of Public Health and Health Education) เป็นลิขสิทธิ์ของ วิทยาลัยการสาธารณสุขสิรินธร จังหวัดอุบลราชธานี
